SYRE
Price
$17.41
Change
+$0.63 (+3.75%)
Updated
Aug 22, 04:59 PM (EDT)
Capitalization
1.05B
75 days until earnings call
TRDA
Price
$6.15
Change
+$0.28 (+4.77%)
Updated
Aug 22, 04:59 PM (EDT)
Capitalization
233.55M
80 days until earnings call
Interact to see
Advertisement

SYRE vs TRDA

Header iconSYRE vs TRDA Comparison
Open Charts SYRE vs TRDABanner chart's image
Spyre Therapeutics
Price$17.41
Change+$0.63 (+3.75%)
Volume$4.83K
Capitalization1.05B
Entrada Therapeutics
Price$6.15
Change+$0.28 (+4.77%)
Volume$4.11K
Capitalization233.55M
SYRE vs TRDA Comparison Chart in %
Loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SYRE vs. TRDA commentary
Aug 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYRE is a Buy and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2025
Stock price -- (SYRE: $17.38 vs. TRDA: $6.14)
Brand notoriety: SYRE and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYRE: 125% vs. TRDA: 97%
Market capitalization -- SYRE: $1.05B vs. TRDA: $233.55M
SYRE [@Biotechnology] is valued at $1.05B. TRDA’s [@Biotechnology] market capitalization is $233.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYRE’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • SYRE’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYRE’s TA Score shows that 7 TA indicator(s) are bullish while TRDA’s TA Score has 6 bullish TA indicator(s).

  • SYRE’s TA Score: 7 bullish, 2 bearish.
  • TRDA’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than TRDA.

Price Growth

SYRE (@Biotechnology) experienced а +2.54% price change this week, while TRDA (@Biotechnology) price change was +16.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.57%. For the same industry, the average monthly price growth was +18.06%, and the average quarterly price growth was +26.94%.

Reported Earning Dates

SYRE is expected to report earnings on Nov 06, 2025.

TRDA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($1.05B) has a higher market cap than TRDA($234M). TRDA has higher P/E ratio than SYRE: TRDA (10.26) vs SYRE (1.72). SYRE YTD gains are higher at: -25.344 vs. TRDA (-64.488). TRDA has higher annual earnings (EBITDA): -92.26M vs. SYRE (-222.15M). SYRE has more cash in the bank: 527M vs. TRDA (354M). SYRE has less debt than TRDA: SYRE (0) vs TRDA (54.7M). TRDA has higher revenues than SYRE: TRDA (79.5M) vs SYRE (0).
SYRETRDASYRE / TRDA
Capitalization1.05B234M449%
EBITDA-222.15M-92.26M241%
Gain YTD-25.344-64.48839%
P/E Ratio1.7210.2617%
Revenue079.5M-
Total Cash527M354M149%
Total Debt054.7M-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SYRETRDA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HVGDF0.07N/A
+3.57%
Harvest Gold Corp.
HENOY21.660.37
+1.71%
Henkel AG & Co. KGAA
MRVSY3.68N/A
N/A
Minerva S.A.
RTMNF1.49N/A
N/A
Reitmans (Canada) Limited
RPYTF155.69N/A
N/A
Reply SPA

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with CGON. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+3.58%
CGON - SYRE
61%
Loosely correlated
+3.60%
IDYA - SYRE
60%
Loosely correlated
+1.99%
BEAM - SYRE
58%
Loosely correlated
+3.94%
XNCR - SYRE
57%
Loosely correlated
+13.04%
CRNX - SYRE
56%
Loosely correlated
+5.17%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+4.60%
CRNX - TRDA
54%
Loosely correlated
+5.17%
BEAM - TRDA
51%
Loosely correlated
+3.94%
XNCR - TRDA
51%
Loosely correlated
+13.04%
IDYA - TRDA
50%
Loosely correlated
+1.99%
SYRE - TRDA
50%
Loosely correlated
+3.58%
More